Mini Llama Antibodies Could Help To Fight SARS-CoV-2 Variants
A new study published in eLife demonstrates the therapeutic potential of nanobodies – miniature antibodies derived from llamas – against SARS-CoV-2.
Applera and Beckman Coulter Announce Final Agreement on Settlement
The agreement terms are consistent with those described in the joint announcement of a preliminary agreement made on April 26, 2006.
Progress Being Made in Exploring Potential use of Stem Cells to Treat Heart Disease
A ccording to a review article in Nature, scientists are making headway in exploring the potential future use of stem cells to treat heart disease.
ProFACT Proteomics Receives New Jersey Entrepreneurial Partnering Fund Award
The funds will, in part, support a $516,000 R&D program with Principal Investigator Kiran Madura, PhD and his laboratory at the UMDNJ.
Nanotechnologies on XXth International Economical Forum in S.Peterbourgh
A great interest showed to nanotechologiy during the XXth International Economical Forum opens wide prospects for its further development.
MicroFluidic Systems Moves to New Facility in Fremont, CA
The new facility will be the center for MFSI's continuing development of its air-borne pathogen detection systems.
Invitrogen and Cellartis Announces Collaboration
Companies announce collaboration to create hESC multi-lineage reporter lines.
Inpharmatica's Admensa Interactive™ Licensed by Lilly
Admensa Interactive combines predictive models with an intuitive desktop interface.
Celsis to Acquire In Vitro Technologies
Companies agree to collaborate due to attractive growth prospects of the in-vitro ADME-Tox market.
Bruker BioSciences Shareholders Approve Acquisition of Bruker Optics
Combined Company to be a leading provider of molecular analysis solutions to the life science.
Aureus licenses AurSCOPE Ion Channel Knowledgebase to Xention
Access to this knowledge database will help Xention to use the selectivity profile and ADMET properties of existing drugs.